Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab + Obinutuzumab + Lenalidomide in R/R Follicular Lymphoma
NCT02631577Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2015
- Primary completion
- Oct 2018
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of atezolizumab in follicular lymphoma (FL), sponsored by Roche. Started Dec 2015; status: completed.
02
Drugs
atezolizumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02631577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631577.